5 completed, 1 unknown, 1 withdrawn. 2 Not applicable, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Withdrawn 1 |
| Phase 3 | 2 | Completed 2 |
Follow Infectious: new trials by email Literature Review of Infectious trials Research Report on Infectious
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Aerosolization During Upper Endoscopy Endoscopic Patient Facemask - Infectious, Gastro-Intestinal Disorder | Not applicable | Completed | Anthony Lembo | 57 | 2021-08-31 | 2025-11-13 |
| Characteristics and Outcomes of Gastrointestinal Manifestations of COVID-19 Laboratory tests - Infectious | Unknown | Assiut University | 200 | 2020-07-01 | 2020-07-29 | |
| Evaluation of "UroShield" Device Impact Upon Side Effects and Complications of Urinary Catheter Usage UroShield device, Sham UroShield device - Infectious | Not applicable | Withdrawn | HaEmek Medical Center, Israel | 2015-08-01 | 2016-09-29 | |
| A Two-Arm, Multi-Centre Clinical Evaluation of the xTAG Gastrointestinal Pathogen Panel Infectious, Colitis | Completed | Luminex Molecular Diagnostics | 1534 | 2011-06-01 | 2012-08-24 | |
| National Study on Listeriosis and Listeria Listeriosis, Pregnancy Complications | Completed | Assistance Publique - Hôpitaux de Paris | 2132 | 2009-11-01 | 2026-03-27 | |
| China Registration Study in Patients With Skin Infections Daptomycin, Vancomycin - Skin Diseases, Infectious | Phase 3 | Completed | AstraZeneca | 265 | 2008-09-01 | 2015-03-09 |
| GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men. darunavir, ritonavir - HIV, Infectious | Phase 3 | Completed | Tibotec, Inc | 429 | 2006-11-01 | 2014-04-21 |
Communicable Diseases (7) · Acquired Immunodeficiency Syndrome (1) · COVID-19 (1) · Cellulitis (1) · Central Nervous System Infections (1) · Colitis (1) · Digestive System Diseases (1) · Gastroenteritis (1) · Listeriosis (1) · Pregnancy Complications (1) · Sepsis (1) · Skin Diseases (1)
Disease Attributes (7) · Infections (7) · Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Inflammation (2) · RNA Virus Infections (2) · Urogenital Diseases (2) · Virus Diseases (2) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Blood-Borne Infections (1) · Central Nervous System Diseases (1) · Colonic Diseases (1) · Connective Tissue Diseases (1) · Coronaviridae Infections (1)
Clinical Laboratory Techniques (1) · Daptomycin (1) · Darunavir (1) · Ritonavir (1) · Vancomycin (1)
Anthony Lembo (1) · Assistance Publique - Hôpitaux de Paris (1) · Assiut University (1) · AstraZeneca (1) · HaEmek Medical Center, Israel (1) · Luminex Molecular Diagnostics (1) · Tibotec, Inc (1)
United States (3) · Canada (2) · China (1) · France (1) · Puerto Rico (1)
Caroline Charlier, MD, PhD (1) · Donna M. Wolk, Ph.D., D.(ABMM) (1) · James Mahony, Ph.D, FCCM, FAAM (1) · Jeremy Liu, Ph.D (1) · John Vargo, MD (1) · Karen Atkin (1) · Lecuit Marc, MD, PhD (1) · Richard Buller, Ph.D., D(ABMM) (1) · Robert C. Fader, Ph.D (1) · Tony Mazzulli, M.D., F.R.C.P.(C), FACP (1) · Yi-Wei Tang, M.D., Ph.D (1) · Zhang Yingyuan, Prof. (1)
PMID 20855799, PMID 23092052, PMID 24396625, PMID 28139432, PMID 29796652, PMID 31955353, PMID 33876229, PMID 37871603